(R)-carnitine multiple interactions EXP 6480464 Carnitine inhibits the reaction [carbendazim results in decreased expression of OCLN protein] CTD PMID:33965443 (S)-amphetamine increases expression ISO RGD:1624078 6480464 Dextroamphetamine results in increased expression of OCLN mRNA CTD PMID:12205029 (S)-amphetamine multiple interactions ISO RGD:1624078 6480464 SOD1 inhibits the reaction [Dextroamphetamine results in increased expression of OCLN mRNA] CTD PMID:12205029 (S)-colchicine decreases expression ISO RGD:1624078 6480464 Colchicine results in decreased expression of OCLN mRNA CTD PMID:33002524 1,10-phenanthroline multiple interactions ISO RGD:732985 6480464 1, 10-phenanthroline inhibits the reaction [Patulin results in increased degradation of OCLN protein] CTD PMID:19013514 1,2-dichloroethane decreases expression ISO RGD:1624078 6480464 ethylene dichloride results in decreased expression of OCLN protein CTD PMID:30081051 1,2-dichloroethane multiple interactions ISO RGD:1624078 6480464 4-(4-fluorophenyl)-2-(4-hydroxyphenyl)-5-(4-pyridyl)imidazole inhibits the reaction [ethylene dichloride results in decreased expression of OCLN protein] more ... CTD PMID:30081051 , PMID:30664321 1,2-dichloroethane increases expression ISO RGD:1624078 6480464 ethylene dichloride results in increased expression of OCLN mRNA CTD PMID:28960355 1,2-dimethylhydrazine decreases expression ISO RGD:1624078 6480464 1, 2-Dimethylhydrazine results in decreased expression of OCLN mRNA CTD PMID:22206623 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine multiple interactions ISO RGD:1624078 6480464 [Probenecid co-treated with 1-Methyl-4-phenyl-1 more ... CTD PMID:25064079 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine decreases expression ISO RGD:1624078 6480464 1-Methyl-4-phenyl-1 more ... CTD PMID:31351185 1-naphthyl isothiocyanate decreases expression ISO RGD:1624078 6480464 1-Naphthylisothiocyanate results in decreased expression of OCLN mRNA, 1-Naphthylisothiocyanate results in decreased expression of OCLN protein CTD PMID:32579994 , PMID:33400020 1-naphthyl isothiocyanate multiple interactions ISO RGD:1624078 6480464 acadesine promotes the reaction [1-Naphthylisothiocyanate results in decreased expression of OCLN protein] more ... CTD PMID:32579994 , PMID:33400020 17beta-estradiol multiple interactions EXP 6480464 Estradiol promotes the reaction [bisphenol A results in decreased expression of OCLN mRNA] CTD PMID:27174447 17beta-estradiol multiple interactions ISO RGD:732985 6480464 [Estradiol co-treated with TGFB1 protein] results in decreased expression of OCLN mRNA CTD PMID:30165855 17beta-estradiol 17-glucosiduronic acid affects localization EXP 6480464 estradiol-17 beta-glucuronide affects the localization of OCLN protein CTD PMID:17463180 17beta-estradiol 3-benzoate multiple interactions EXP 6480464 fulvestrant inhibits the reaction [estradiol 3-benzoate results in increased expression of OCLN mRNA] CTD PMID:19433574 17beta-estradiol 3-benzoate increases expression EXP 6480464 estradiol 3-benzoate results in increased expression of OCLN mRNA, estradiol 3-benzoate results in increased expression of OCLN protein CTD PMID:19433574 17beta-estradiol 3-benzoate multiple interactions ISO RGD:732985 6480464 fulvestrant inhibits the reaction [estradiol 3-benzoate results in increased expression of OCLN mRNA], fulvestrant inhibits the reaction [estradiol 3-benzoate results in increased expression of OCLN protein] CTD PMID:19433574 17beta-estradiol 3-benzoate increases expression ISO RGD:732985 6480464 estradiol 3-benzoate results in increased expression of OCLN mRNA, estradiol 3-benzoate results in increased expression of OCLN protein CTD PMID:19433574 2,2',4,4',5,5'-hexachlorobiphenyl decreases expression ISO RGD:732985 6480464 2 more ... CTD PMID:20299304 2,2',4,4',5,5'-hexachlorobiphenyl multiple interactions ISO RGD:1624078 6480464 2 more ... CTD PMID:20064788 2,2',4,4',5,5'-hexachlorobiphenyl decreases expression EXP 6480464 2 more ... CTD PMID:20299304 2,3',4,4',5-Pentachlorobiphenyl decreases expression ISO RGD:732985 6480464 2 more ... CTD PMID:20299304 2,3',4,4',5-Pentachlorobiphenyl multiple interactions ISO RGD:732985 6480464 [2 more ... CTD PMID:22906770 2,3',4,4',5-Pentachlorobiphenyl decreases expression EXP 6480464 2 more ... CTD PMID:20299304 2,3',4,4',5-Pentachlorobiphenyl multiple interactions ISO RGD:1624078 6480464 2 more ... CTD PMID:20064788 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO RGD:732985 6480464 Tetrachlorodibenzodioxin results in increased expression of OCLN mRNA CTD PMID:23152189 2,3,7,8-tetrachlorodibenzodioxine decreases expression EXP 6480464 Tetrachlorodibenzodioxin results in decreased expression of OCLN mRNA CTD PMID:33387578 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO RGD:1624078 6480464 Tetrachlorodibenzodioxin results in decreased expression of OCLN mRNA CTD PMID:33956508 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO RGD:1624078 6480464 [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in increased expression of OCLN mRNA CTD PMID:25975270 2,3-bis(4-hydroxyphenyl)propionitrile increases expression ISO RGD:732985 6480464 2 more ... CTD PMID:19433574 2,3-bis(4-hydroxyphenyl)propionitrile multiple interactions ISO RGD:732985 6480464 Fulvestrant inhibits the reaction [2 more ... CTD PMID:19433574 2,4,6-trinitrobenzenesulfonic acid decreases expression ISO RGD:1624078 6480464 Trinitrobenzenesulfonic Acid results in decreased expression of OCLN mRNA, Trinitrobenzenesulfonic Acid results in decreased expression of OCLN protein CTD PMID:22147983 more ... 2,4,6-trinitrobenzenesulfonic acid multiple interactions EXP 6480464 oxymatrine inhibits the reaction [Trinitrobenzenesulfonic Acid results in decreased expression of OCLN mRNA] more ... CTD PMID:35290143 2,4,6-trinitrobenzenesulfonic acid decreases expression EXP 6480464 Trinitrobenzenesulfonic Acid results in decreased expression of OCLN mRNA, Trinitrobenzenesulfonic Acid results in decreased expression of OCLN protein CTD PMID:35290143 2,4,6-trinitrobenzenesulfonic acid multiple interactions ISO RGD:1624078 6480464 Dexamethasone inhibits the reaction [Trinitrobenzenesulfonic Acid results in decreased expression of OCLN mRNA], ginsenoside Re inhibits the reaction [Trinitrobenzenesulfonic Acid results in decreased expression of OCLN protein] CTD PMID:22849695 , PMID:25307695 2,4-D decreases expression EXP 6480464 2, 4-Dichlorophenoxyacetic Acid results in decreased expression of OCLN mRNA CTD PMID:28699141 3,3',4,4',5-pentachlorobiphenyl multiple interactions ISO RGD:1624078 6480464 3 more ... CTD PMID:20064788 3,3',4,4',5-pentachlorobiphenyl increases expression EXP 6480464 3 more ... CTD PMID:23196670 3,3',4,4',5-pentachlorobiphenyl decreases expression ISO RGD:732985 6480464 3 more ... CTD PMID:20299304 3,3',5-triiodo-L-thyronine increases expression EXP 6480464 Triiodothyronine results in increased expression of OCLN mRNA CTD PMID:15953391 3-\{1-[3-(dimethylamino)propyl]-1H-indol-3-yl\}-4-(1H-indol-3-yl)-1H-pyrrole-2,5-dione multiple interactions ISO RGD:732985 6480464 bisindolylmaleimide I inhibits the reaction [Cadmium Chloride affects the localization of OCLN protein] more ... CTD PMID:25851441 , PMID:28780155 4,4'-sulfonyldiphenol increases expression ISO RGD:1624078 6480464 bis(4-hydroxyphenyl)sulfone results in increased expression of OCLN mRNA CTD PMID:30951980 4,4'-sulfonyldiphenol multiple interactions ISO RGD:1624078 6480464 [bis(4-hydroxyphenyl)sulfone co-treated with Tretinoin] results in decreased expression of OCLN mRNA CTD PMID:30951980 4-(N-nitrosomethylamino)-1-(3-pyridyl)butan-1-one decreases expression ISO RGD:732985 6480464 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in decreased expression of OCLN protein CTD PMID:30236600 4-\{[(5,5,8,8-tetramethyl-5,6,7,8-tetrahydronaphthalen-2-yl)carbonyl]amino\}benzoic acid increases expression ISO RGD:732985 6480464 Am 580 results in increased expression of OCLN mRNA CTD PMID:16982755 4-hydroxyphenyl retinamide increases expression ISO RGD:1624078 6480464 Fenretinide results in increased expression of OCLN mRNA CTD PMID:28973697 4-hydroxyphenyl retinamide decreases expression ISO RGD:1624078 6480464 Fenretinide results in decreased expression of OCLN mRNA CTD PMID:28973697 4-phenylbutyric acid multiple interactions ISO RGD:1624078 6480464 4-phenylbutyric acid inhibits the reaction [Busulfan results in decreased expression of OCLN protein] CTD PMID:35533795 4-tert-Octylphenol decreases expression EXP 6480464 4-tert-octylphenol results in decreased expression of OCLN protein CTD PMID:15082077 5-azacytidine increases expression ISO RGD:732985 6480464 Azacitidine results in increased expression of OCLN mRNA CTD PMID:18661270 6-chloro-2,3,4,9-tetrahydro-1H-carbazole-1-carboxamide multiple interactions ISO RGD:732985 6480464 6-chloro-2 more ... CTD PMID:31472180 6-propyl-2-thiouracil increases expression EXP 6480464 Propylthiouracil results in increased expression of OCLN mRNA CTD PMID:24780913 acadesine multiple interactions ISO RGD:1624078 6480464 acadesine promotes the reaction [1-Naphthylisothiocyanate results in decreased expression of OCLN protein] CTD PMID:33400020 acetaldehyde multiple interactions ISO RGD:732985 6480464 EGF protein inhibits the reaction [Acetaldehyde affects the localization of OCLN protein], PLCG1 protein affects the reaction [EGF protein inhibits the reaction [Acetaldehyde affects the localization of OCLN protein]] CTD PMID:17991733 acetaldehyde affects localization ISO RGD:732985 6480464 Acetaldehyde affects the localization of OCLN protein CTD PMID:22563376 acrylonitrile decreases expression ISO RGD:732985 6480464 Acrylonitrile results in decreased expression of OCLN protein CTD PMID:30236600 actinidine increases cleavage ISO RGD:732985 6480464 actinidine results in increased cleavage of OCLN protein CTD PMID:25042511 aflatoxin B1 decreases expression ISO RGD:732985 6480464 Aflatoxin B1 results in decreased expression of OCLN mRNA CTD PMID:22100608 , PMID:27153755 aflatoxin B1 decreases expression ISO RGD:1624078 6480464 Aflatoxin B1 results in decreased expression of OCLN protein CTD PMID:33421461 aflatoxin B1 increases methylation ISO RGD:732985 6480464 Aflatoxin B1 results in increased methylation of OCLN intron CTD PMID:30157460 aflatoxin B1 decreases methylation ISO RGD:732985 6480464 Aflatoxin B1 results in decreased methylation of OCLN gene CTD PMID:27153756 aldehydo-D-glucose decreases expression ISO RGD:732985 6480464 Glucose results in decreased expression of OCLN mRNA, Glucose results in decreased expression of OCLN protein CTD PMID:21617913 more ... aldehydo-D-glucose multiple interactions ISO RGD:732985 6480464 MYLK protein inhibits the reaction [Telmisartan inhibits the reaction [Glucose results in decreased expression of OCLN mRNA]] more ... CTD PMID:34464088 aldehydo-D-glucose decreases expression ISO RGD:1624078 6480464 Glucose results in decreased expression of OCLN protein CTD PMID:21617913 all-trans-retinoic acid increases expression ISO RGD:732985 6480464 Tretinoin results in increased expression of OCLN mRNA CTD PMID:16982755 all-trans-retinoic acid decreases expression ISO RGD:732985 6480464 Tretinoin results in decreased expression of OCLN mRNA CTD PMID:33167477 all-trans-retinoic acid multiple interactions ISO RGD:1624078 6480464 [bis(4-hydroxyphenyl)sulfone co-treated with Tretinoin] results in decreased expression of OCLN mRNA CTD PMID:30951980 alpha,alpha-trehalose multiple interactions ISO RGD:1624078 6480464 Trehalose inhibits the reaction [[Probenecid co-treated with 1-Methyl-4-phenyl-1 more ... CTD PMID:25064079 alpha-D-galactose decreases expression ISO RGD:1624078 6480464 Galactose results in decreased expression of OCLN protein CTD PMID:33516661 ammonium chloride affects expression EXP 6480464 Ammonium Chloride affects the expression of OCLN mRNA CTD PMID:16483693 Ammothamnine multiple interactions EXP 6480464 oxymatrine inhibits the reaction [Trinitrobenzenesulfonic Acid results in decreased expression of OCLN mRNA], oxymatrine inhibits the reaction [Trinitrobenzenesulfonic Acid results in decreased expression of OCLN protein] CTD PMID:35290143 ampicillin multiple interactions ISO RGD:1624078 6480464 [Neomycin co-treated with Metronidazole co-treated with Ampicillin co-treated with Vancomycin] inhibits the reaction [Methamphetamine results in decreased expression of OCLN mRNA], [Neomycin co-treated with Metronidazole co-treated with Ampicillin co-treated with Vancomycin] inhibits the reaction [Methamphetamine results in decreased expression of OCLN protein] CTD PMID:35390362 arsane multiple interactions ISO RGD:732985 6480464 Arsenic affects the phosphorylation of and results in increased expression of OCLN protein CTD PMID:24349408 arsane decreases expression EXP 6480464 Arsenic results in decreased expression of OCLN mRNA CTD PMID:28829631 arsane affects methylation ISO RGD:732985 6480464 Arsenic affects the methylation of OCLN gene CTD PMID:25304211 arsane increases expression ISO RGD:732985 6480464 Arsenic results in increased expression of OCLN protein CTD PMID:24349408 arsane affects localization ISO RGD:1624078 6480464 Arsenic affects the localization of OCLN protein CTD PMID:24349408 arsenic atom multiple interactions ISO RGD:732985 6480464 Arsenic affects the phosphorylation of and results in increased expression of OCLN protein CTD PMID:24349408 arsenic atom decreases expression EXP 6480464 Arsenic results in decreased expression of OCLN mRNA CTD PMID:28829631 arsenic atom affects methylation ISO RGD:732985 6480464 Arsenic affects the methylation of OCLN gene CTD PMID:25304211 arsenic atom affects localization ISO RGD:1624078 6480464 Arsenic affects the localization of OCLN protein CTD PMID:24349408 arsenic atom increases expression ISO RGD:732985 6480464 Arsenic results in increased expression of OCLN protein CTD PMID:24349408 arsenous acid decreases expression ISO RGD:1624078 6480464 Arsenic Trioxide results in decreased expression of OCLN mRNA, Arsenic Trioxide results in decreased expression of OCLN protein CTD PMID:30032600 more ... arsenous acid decreases expression ISO RGD:732985 6480464 Arsenic Trioxide results in decreased expression of OCLN mRNA, Arsenic Trioxide results in decreased expression of OCLN protein CTD PMID:32683294 arsenous acid multiple interactions ISO RGD:732985 6480464 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [Arsenic Trioxide results in decreased expression of OCLN protein] more ... CTD PMID:32683294 benzalkonium chloride decreases expression ISO RGD:1624078 6480464 Benzalkonium Compounds results in decreased expression of OCLN protein CTD PMID:29514330 benzo[a]pyrene decreases expression ISO RGD:1624078 6480464 Benzo(a)pyrene results in decreased expression of OCLN mRNA CTD PMID:22228805 benzo[a]pyrene decreases expression ISO RGD:732985 6480464 Benzo(a)pyrene results in decreased expression of OCLN protein CTD PMID:30236600 benzo[a]pyrene affects methylation ISO RGD:732985 6480464 Benzo(a)pyrene affects the methylation of OCLN 5' UTR, Benzo(a)pyrene affects the methylation of OCLN promoter CTD PMID:27901495 beta-naphthoflavone increases expression ISO RGD:732985 6480464 beta-Naphthoflavone results in increased expression of OCLN mRNA CTD PMID:32151702 bis(2-chloroethyl) sulfide increases expression ISO RGD:1624078 6480464 Mustard Gas results in increased expression of OCLN mRNA CTD PMID:15674843 bisphenol A decreases expression EXP 6480464 bisphenol A results in decreased expression of OCLN mRNA, bisphenol A results in decreased expression of OCLN protein CTD PMID:15082077 more ... bisphenol A multiple interactions ISO RGD:732985 6480464 [bisphenol A co-treated with Fulvestrant] results in increased methylation of OCLN gene CTD PMID:31601247 bisphenol A multiple interactions ISO RGD:1624078 6480464 4-methyl-N1-(3-phenylpropyl)benzene-1 more ... CTD PMID:33485121 bisphenol A decreases expression ISO RGD:1624078 6480464 bisphenol A results in decreased expression of OCLN mRNA, bisphenol A results in decreased expression of OCLN protein CTD PMID:30951980 more ... bisphenol A multiple interactions EXP 6480464 bisphenol A results in decreased expression of and affects the localization of OCLN protein, Estradiol promotes the reaction [bisphenol A results in decreased expression of OCLN mRNA] CTD PMID:19497385 , PMID:27174447 bisphenol A affects expression EXP 6480464 bisphenol A affects the expression of OCLN mRNA CTD PMID:25181051 bisphenol A decreases expression ISO RGD:732985 6480464 bisphenol A results in decreased expression of OCLN protein CTD PMID:26922907 bisphenol A increases expression ISO RGD:1624078 6480464 bisphenol A results in increased expression of OCLN mRNA CTD PMID:22435627 more ... bisphenol F increases expression ISO RGD:1624078 6480464 bisphenol F results in increased expression of OCLN mRNA CTD PMID:30951980 busulfan decreases expression ISO RGD:1624078 6480464 Busulfan results in decreased expression of OCLN mRNA, Busulfan results in decreased expression of OCLN protein CTD PMID:35533795 busulfan multiple interactions ISO RGD:1624078 6480464 4-phenylbutyric acid inhibits the reaction [Busulfan results in decreased expression of OCLN protein] CTD PMID:35533795 butyric acid multiple interactions ISO RGD:1624078 6480464 Butyric Acid inhibits the reaction [[Permethrin co-treated with Pyridostigmine Bromide co-treated with Corticosterone] results in decreased expression of OCLN protein] CTD PMID:29751049 cadmium atom multiple interactions EXP 6480464 [Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of OCLN mRNA more ... CTD PMID:31390532 cadmium atom decreases expression EXP 6480464 Cadmium results in decreased expression of OCLN mRNA CTD PMID:28829631 cadmium dichloride decreases expression EXP 6480464 Cadmium Chloride results in decreased expression of OCLN protein CTD PMID:15618353 cadmium dichloride increases phosphorylation ISO RGD:732985 6480464 Cadmium Chloride results in increased phosphorylation of OCLN protein CTD PMID:25851441 cadmium dichloride increases expression ISO RGD:732985 6480464 Cadmium Chloride results in increased expression of OCLN mRNA CTD PMID:25851441 cadmium dichloride multiple interactions ISO RGD:732985 6480464 bisindolylmaleimide I inhibits the reaction [Cadmium Chloride affects the localization of OCLN protein] more ... CTD PMID:25851441 cadmium dichloride multiple interactions EXP 6480464 [Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of OCLN mRNA more ... CTD PMID:15618353 , PMID:31390532 caffeine affects phosphorylation ISO RGD:732985 6480464 Caffeine affects the phosphorylation of OCLN protein CTD PMID:35688186 calcitriol increases expression ISO RGD:732985 6480464 Calcitriol results in increased expression of OCLN mRNA CTD PMID:26485663 calcium atom multiple interactions ISO RGD:732985 6480464 Calcium deficiency inhibits the reaction [TJP1 protein binds to OCLN protein] CTD PMID:11054866 calcium(0) multiple interactions ISO RGD:732985 6480464 Calcium deficiency inhibits the reaction [TJP1 protein binds to OCLN protein] CTD PMID:11054866 carbendazim decreases expression EXP 6480464 carbendazim results in decreased expression of OCLN protein CTD PMID:33965443 carbendazim multiple interactions EXP 6480464 Carnitine inhibits the reaction [carbendazim results in decreased expression of OCLN protein] CTD PMID:33965443 carbon nanotube increases expression ISO RGD:1624078 6480464 Nanotubes more ... CTD PMID:25554681 carbon nanotube decreases expression ISO RGD:1624078 6480464 Nanotubes more ... CTD PMID:25620056 , PMID:32413421 chlorogenic acid multiple interactions EXP 6480464 Chlorogenic Acid inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of OCLN mRNA], Chlorogenic Acid inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of OCLN protein] CTD PMID:31390532 chloroquine increases expression ISO RGD:732985 6480464 Chloroquine results in increased expression of OCLN mRNA CTD PMID:25752684 chlorpyrifos increases expression EXP 6480464 Chlorpyrifos results in increased expression of OCLN mRNA CTD PMID:25019507 choline multiple interactions ISO RGD:1624078 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of and results in increased expression of OCLN, [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of OCLN gene CTD PMID:20938992 chromium(6+) decreases expression EXP 6480464 chromium hexavalent ion results in decreased expression of OCLN mRNA, chromium hexavalent ion results in decreased expression of OCLN protein CTD PMID:32679048 cisplatin decreases expression ISO RGD:732985 6480464 Cisplatin results in decreased expression of OCLN mRNA CTD PMID:27392435 cisplatin multiple interactions ISO RGD:732985 6480464 [Cisplatin co-treated with jinfukang] results in decreased expression of OCLN mRNA CTD PMID:27392435 clopidogrel decreases expression ISO RGD:732985 6480464 clopidogrel results in decreased expression of OCLN protein CTD PMID:23220562 clopidogrel multiple interactions ISO RGD:732985 6480464 SB 203580 inhibits the reaction [clopidogrel results in decreased expression of OCLN protein] CTD PMID:23220562 cobalt dichloride decreases expression ISO RGD:732985 6480464 cobaltous chloride results in decreased expression of OCLN protein CTD PMID:19324842 cobalt dichloride decreases expression ISO RGD:1624078 6480464 cobaltous chloride results in decreased expression of OCLN protein CTD PMID:21617913 copper atom multiple interactions ISO RGD:732985 6480464 [NSC 689534 binds to Copper] which results in increased expression of OCLN mRNA CTD PMID:20971185 copper(0) multiple interactions ISO RGD:732985 6480464 [NSC 689534 binds to Copper] which results in increased expression of OCLN mRNA CTD PMID:20971185 corticosterone multiple interactions ISO RGD:1624078 6480464 [Permethrin co-treated with Pyridostigmine Bromide co-treated with Corticosterone] results in decreased expression of OCLN protein, Butyric Acid inhibits the reaction [[Permethrin co-treated with Pyridostigmine Bromide co-treated with Corticosterone] results in decreased expression of OCLN protein] CTD PMID:29751049 cortisol increases expression ISO RGD:732985 6480464 Hydrocortisone results in increased expression of OCLN mRNA CTD PMID:25763180 curcumin multiple interactions ISO RGD:1624078 6480464 Curcumin inhibits the reaction [deoxynivalenol results in decreased expression of OCLN mRNA], Curcumin inhibits the reaction [deoxynivalenol results in decreased expression of OCLN protein] CTD PMID:35817260 cyclophosphamide decreases expression ISO RGD:1624078 6480464 Cyclophosphamide results in decreased expression of OCLN protein CTD PMID:32151603 cyclophosphamide increases expression EXP 6480464 Cyclophosphamide results in increased expression of OCLN protein CTD PMID:32615180 cyclophosphamide multiple interactions EXP 6480464 O-1602 compound inhibits the reaction [Cyclophosphamide results in increased expression of OCLN protein] CTD PMID:32615180 cyclophosphamide multiple interactions ISO RGD:1624078 6480464 Fungal Polysaccharides inhibits the reaction [Cyclophosphamide results in decreased expression of OCLN protein] CTD PMID:32151603 D-glucose decreases expression ISO RGD:732985 6480464 Glucose results in decreased expression of OCLN mRNA, Glucose results in decreased expression of OCLN protein CTD PMID:21617913 more ... D-glucose multiple interactions ISO RGD:732985 6480464 MYLK protein inhibits the reaction [Telmisartan inhibits the reaction [Glucose results in decreased expression of OCLN mRNA]] more ... CTD PMID:34464088 D-glucose decreases expression ISO RGD:1624078 6480464 Glucose results in decreased expression of OCLN protein CTD PMID:21617913 decabromodiphenyl ether decreases expression ISO RGD:732985 6480464 decabromobiphenyl ether results in decreased expression of OCLN mRNA, decabromobiphenyl ether results in decreased expression of OCLN protein CTD PMID:33675858 decabromodiphenyl ether multiple interactions ISO RGD:732985 6480464 Luteolin inhibits the reaction [decabromobiphenyl ether results in decreased expression of OCLN mRNA], Luteolin inhibits the reaction [decabromobiphenyl ether results in decreased expression of OCLN protein] CTD PMID:33675858 deoxynivalenol affects localization ISO RGD:732985 6480464 deoxynivalenol affects the localization of OCLN protein CTD PMID:24568843 deoxynivalenol decreases expression ISO RGD:1624078 6480464 deoxynivalenol results in decreased expression of OCLN mRNA, deoxynivalenol results in decreased expression of OCLN protein CTD PMID:34506767 , PMID:35817260 deoxynivalenol multiple interactions ISO RGD:1624078 6480464 Curcumin inhibits the reaction [deoxynivalenol results in decreased expression of OCLN mRNA] more ... CTD PMID:34506767 , PMID:35817260 deoxynivalenol increases expression ISO RGD:732985 6480464 deoxynivalenol results in increased expression of OCLN mRNA CTD PMID:20362602 , PMID:24568843 dexamethasone multiple interactions ISO RGD:1624078 6480464 Dexamethasone inhibits the reaction [Trinitrobenzenesulfonic Acid results in decreased expression of OCLN mRNA] CTD PMID:25307695 dextran sulfate decreases expression ISO RGD:1624078 6480464 Dextran Sulfate results in decreased expression of OCLN mRNA, Dextran Sulfate results in decreased expression of OCLN protein CTD PMID:23261717 more ... dextran sulfate multiple interactions ISO RGD:1624078 6480464 [Dietary Fats co-treated with Dextran Sulfate] results in increased expression of OCLN protein more ... CTD PMID:27995407 , PMID:35439472 diarsenic trioxide decreases expression ISO RGD:1624078 6480464 Arsenic Trioxide results in decreased expression of OCLN mRNA, Arsenic Trioxide results in decreased expression of OCLN protein CTD PMID:30032600 more ... diarsenic trioxide decreases expression ISO RGD:732985 6480464 Arsenic Trioxide results in decreased expression of OCLN mRNA, Arsenic Trioxide results in decreased expression of OCLN protein CTD PMID:32683294 diarsenic trioxide multiple interactions ISO RGD:732985 6480464 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [Arsenic Trioxide results in decreased expression of OCLN protein] more ... CTD PMID:32683294 dibutyl phthalate increases expression EXP 6480464 Dibutyl Phthalate results in increased expression of OCLN mRNA CTD PMID:21266533 diclofenac decreases expression ISO RGD:732985 6480464 Diclofenac results in decreased expression of OCLN mRNA CTD PMID:29027214 diclofenac decreases expression EXP 6480464 Diclofenac results in decreased expression of OCLN mRNA CTD PMID:29027214 Dictamnine multiple interactions ISO RGD:732985 6480464 [dictamnine co-treated with Oxygen deficiency] results in increased expression of OCLN protein more ... CTD PMID:30266538 diiodine multiple interactions ISO RGD:732985 6480464 [gamma-Linolenic Acid co-treated with Iodine co-treated with Selenium] results in increased expression of and results in increased localization of OCLN protein more ... CTD PMID:16514648 dimethyl sulfoxide increases expression ISO RGD:732985 6480464 Dimethyl Sulfoxide results in increased expression of OCLN mRNA CTD PMID:18661270 dioxygen multiple interactions EXP 6480464 Lipopolysaccharides promotes the reaction [Oxygen deficiency results in decreased expression of OCLN protein] more ... CTD PMID:23082119 dioxygen multiple interactions ISO RGD:1624078 6480464 [Oxygen deficiency co-treated with Blood Glucose deficiency] results in decreased expression of OCLN mRNA more ... CTD PMID:31816286 dioxygen multiple interactions ISO RGD:732985 6480464 [dictamnine co-treated with Oxygen deficiency] results in increased expression of OCLN protein more ... CTD PMID:30266538 , PMID:31816286 dioxygen decreases expression EXP 6480464 Oxygen deficiency results in decreased expression of OCLN protein CTD PMID:23082119 dizocilpine maleate multiple interactions ISO RGD:1624078 6480464 Dizocilpine Maleate inhibits the reaction [Excitatory Amino Acid Agonists results in decreased expression of OCLN protein] CTD PMID:26655082 dodecanoic acid multiple interactions ISO RGD:1624078 6480464 lauric acid inhibits the reaction [deoxynivalenol results in decreased expression of OCLN protein] CTD PMID:34506767 dorsomorphin multiple interactions ISO RGD:1624078 6480464 dorsomorphin inhibits the reaction [1-Naphthylisothiocyanate results in decreased expression of OCLN protein] CTD PMID:33400020 dorsomorphin multiple interactions ISO RGD:732985 6480464 [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of OCLN mRNA CTD PMID:27188386 elemental selenium multiple interactions ISO RGD:732985 6480464 [gamma-Linolenic Acid co-treated with Iodine co-treated with Selenium] results in increased expression of and results in increased localization of OCLN protein more ... CTD PMID:16514648 endosulfan decreases expression EXP 6480464 Endosulfan results in decreased expression of OCLN mRNA CTD PMID:31464424 epoxiconazole increases expression ISO RGD:1624078 6480464 epoxiconazole results in increased expression of OCLN mRNA CTD PMID:35436446 ethanol decreases expression ISO RGD:732985 6480464 Ethanol results in decreased expression of OCLN protein CTD PMID:25226407 ethanol multiple interactions ISO RGD:1624078 6480464 [ethylene dichloride co-treated with Ethanol] results in decreased expression of OCLN mRNA more ... CTD PMID:30664321 more ... ethanol decreases expression ISO RGD:1624078 6480464 Ethanol results in decreased expression of OCLN protein CTD PMID:31785310 ethanol multiple interactions ISO RGD:732985 6480464 Ethanol results in decreased expression of and affects the localization of OCLN protein, Plant Extracts inhibits the reaction [Ethanol results in decreased expression of and affects the localization of OCLN protein] CTD PMID:28412402 ethanol affects localization ISO RGD:732985 6480464 Ethanol affects the localization of OCLN protein CTD PMID:22563376 , PMID:25226407 excitatory amino acid agonist multiple interactions ISO RGD:1624078 6480464 Dizocilpine Maleate inhibits the reaction [Excitatory Amino Acid Agonists results in decreased expression of OCLN protein] CTD PMID:26655082 excitatory amino acid agonist decreases expression ISO RGD:1624078 6480464 Excitatory Amino Acid Agonists results in decreased expression of OCLN protein CTD PMID:26655082 flutamide decreases expression EXP 6480464 Flutamide results in decreased expression of OCLN mRNA CTD PMID:24136188 folic acid multiple interactions ISO RGD:1624078 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of and results in increased expression of OCLN, [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of OCLN gene CTD PMID:20938992 fulvestrant multiple interactions EXP 6480464 fulvestrant inhibits the reaction [estradiol 3-benzoate results in increased expression of OCLN mRNA] CTD PMID:19433574 fulvestrant multiple interactions ISO RGD:732985 6480464 [bisphenol A co-treated with Fulvestrant] results in increased methylation of OCLN gene more ... CTD PMID:19433574 , PMID:31601247 fumonisin B1 multiple interactions ISO RGD:732985 6480464 illite inhibits the reaction [fumonisin B1 results in decreased expression of OCLN mRNA] CTD PMID:27153755 fumonisin B1 decreases expression ISO RGD:732985 6480464 fumonisin B1 results in decreased expression of OCLN mRNA CTD PMID:27153755 furan decreases expression ISO RGD:1624078 6480464 furan results in decreased expression of OCLN protein CTD PMID:32251705 furan multiple interactions ISO RGD:1624078 6480464 rhodioloside affects the reaction [furan results in decreased expression of OCLN protein] CTD PMID:32251705 galactose decreases expression ISO RGD:1624078 6480464 Galactose results in decreased expression of OCLN protein CTD PMID:33516661 gamma-linolenic acid multiple interactions ISO RGD:732985 6480464 [gamma-Linolenic Acid co-treated with Iodine co-treated with Selenium] results in increased expression of and results in increased localization of OCLN protein more ... CTD PMID:16514648 genistein decreases expression ISO RGD:732985 6480464 Genistein results in decreased expression of OCLN mRNA CTD PMID:20816778 gentamycin decreases expression EXP 6480464 Gentamicins results in decreased expression of OCLN mRNA CTD PMID:33387578 Ginkgolide A multiple interactions ISO RGD:1624078 6480464 ginkgolide A inhibits the reaction [Carbon Tetrachloride results in decreased expression of OCLN protein] CTD PMID:31697926 ginsenoside Re multiple interactions ISO RGD:1624078 6480464 ginsenoside Re inhibits the reaction [Trinitrobenzenesulfonic Acid results in decreased expression of OCLN protein] CTD PMID:22849695 glucose decreases expression ISO RGD:732985 6480464 Glucose results in decreased expression of OCLN mRNA, Glucose results in decreased expression of OCLN protein CTD PMID:21617913 more ... glucose multiple interactions ISO RGD:732985 6480464 MYLK protein inhibits the reaction [Telmisartan inhibits the reaction [Glucose results in decreased expression of OCLN mRNA]] more ... CTD PMID:34464088 glucose decreases expression ISO RGD:1624078 6480464 Glucose results in decreased expression of OCLN protein CTD PMID:21617913 glycine decreases expression ISO RGD:732985 6480464 Glycine results in decreased expression of OCLN protein CTD PMID:30605748 glyphosate decreases expression ISO RGD:732985 6480464 glyphosate results in decreased expression of OCLN protein CTD PMID:30605748 hydrogen peroxide affects expression ISO RGD:732985 6480464 Hydrogen Peroxide affects the expression of OCLN mRNA CTD PMID:18661270 hydrogen peroxide multiple interactions ISO RGD:732985 6480464 Quercetin inhibits the reaction [Hydrogen Peroxide results in decreased expression of OCLN protein] CTD PMID:20445016 hydrogen peroxide decreases expression ISO RGD:732985 6480464 Hydrogen Peroxide results in decreased expression of OCLN protein CTD PMID:20445016 hydrogen peroxide increases response to substance ISO RGD:1624078 6480464 OCLN protein results in increased susceptibility to Hydrogen Peroxide CTD PMID:16982755 hydrogen peroxide multiple interactions ISO RGD:1624078 6480464 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [OCLN protein results in increased susceptibility to Hydrogen Peroxide] CTD PMID:16982755 hydrogen sulfide multiple interactions ISO RGD:1624078 6480464 [Hydrogen Sulfide results in increased abundance of sodium sulfide] which results in decreased expression of OCLN protein more ... CTD PMID:33068716 hydroquinone multiple interactions EXP 6480464 hydroquinone results in decreased degradation of and results in increased expression of OCLN protein CTD PMID:27587462 hydroxychloroquine increases expression ISO RGD:732985 6480464 Hydroxychloroquine results in increased expression of OCLN mRNA CTD PMID:25752684 indometacin decreases expression ISO RGD:732985 6480464 Indomethacin results in decreased expression of OCLN mRNA CTD PMID:23668856 , PMID:29027214 indometacin multiple interactions EXP 6480464 myricetin inhibits the reaction [Indomethacin results in decreased expression of OCLN mRNA] more ... CTD PMID:33276066 indometacin decreases expression EXP 6480464 Indomethacin results in decreased expression of OCLN mRNA, Indomethacin results in decreased expression of OCLN protein CTD PMID:29027214 , PMID:33276066 indometacin multiple interactions ISO RGD:732985 6480464 Quercetin inhibits the reaction [Indomethacin results in decreased expression of OCLN mRNA] CTD PMID:23668856 iron atom multiple interactions EXP 6480464 Iron inhibits the reaction [Lead results in decreased expression of OCLN mRNA], Iron inhibits the reaction [Lead results in decreased expression of OCLN protein] CTD PMID:17234227 iron(0) multiple interactions EXP 6480464 Iron inhibits the reaction [Lead results in decreased expression of OCLN mRNA], Iron inhibits the reaction [Lead results in decreased expression of OCLN protein] CTD PMID:17234227 isoprene decreases expression ISO RGD:732985 6480464 isoprene results in decreased expression of OCLN protein CTD PMID:30236600 kaempferol multiple interactions ISO RGD:1624078 6480464 kaempferol inhibits the reaction [Ethanol results in decreased expression of OCLN protein] CTD PMID:31785310 ketamine multiple interactions ISO RGD:1624078 6480464 Ketamine inhibits the reaction [KNG1 protein results in increased expression of OCLN protein] CTD PMID:27638051 kynurenic acid multiple interactions ISO RGD:1624078 6480464 Kynurenic Acid inhibits the reaction [lipopolysaccharide, E coli O55-B5 results in decreased expression of OCLN protein] CTD PMID:35123988 L-ascorbic acid multiple interactions EXP 6480464 [Ascorbic Acid co-treated with Vitamin E] inhibits the reaction [mono-(2-ethylhexyl)phthalate affects the localization of OCLN protein] CTD PMID:29940330 L-methionine multiple interactions ISO RGD:1624078 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of and results in increased expression of OCLN, [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of OCLN gene CTD PMID:20938992 lead diacetate decreases expression ISO RGD:732985 6480464 lead acetate results in decreased expression of OCLN protein CTD PMID:24200059 lead diacetate multiple interactions ISO RGD:732985 6480464 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [lead acetate results in decreased expression of OCLN protein], 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [lead acetate results in decreased expression of OCLN protein] CTD PMID:24200059 lead(0) multiple interactions EXP 6480464 [malaoxon co-treated with Lead] results in decreased expression of OCLN protein more ... CTD PMID:17234227 more ... lead(0) decreases expression EXP 6480464 Lead results in decreased expression of OCLN mRNA, Lead results in decreased expression of OCLN protein CTD PMID:17234227 more ... lead(2+) multiple interactions EXP 6480464 [malaoxon co-treated with Lead] results in decreased expression of OCLN protein more ... CTD PMID:17234227 more ... lead(2+) decreases expression EXP 6480464 Lead results in decreased expression of OCLN mRNA, Lead results in decreased expression of OCLN protein CTD PMID:17234227 more ... lipopolysaccharide multiple interactions ISO RGD:732985 6480464 [2 more ... CTD PMID:22906770 lipopolysaccharide increases expression EXP 6480464 Lipopolysaccharides results in increased expression of OCLN protein CTD PMID:15763998 lipopolysaccharide multiple interactions EXP 6480464 Lipopolysaccharides promotes the reaction [Oxygen deficiency results in decreased expression of OCLN protein], prolinedithiocarbamate inhibits the reaction [Lipopolysaccharides promotes the reaction [Oxygen deficiency results in decreased expression of OCLN protein]] CTD PMID:23082119 lipopolysaccharide increases expression ISO RGD:1624078 6480464 Lipopolysaccharides results in increased expression of OCLN mRNA CTD PMID:12057914 lithium chloride decreases expression ISO RGD:1624078 6480464 Lithium Chloride results in decreased expression of OCLN mRNA CTD PMID:33901603 lithium chloride increases expression ISO RGD:1624078 6480464 Lithium Chloride results in increased expression of OCLN protein CTD PMID:33901603 lithocholic acid multiple interactions ISO RGD:732985 6480464 Lithocholic Acid inhibits the reaction [6-chloro-2 more ... CTD PMID:31472180 luteolin multiple interactions ISO RGD:732985 6480464 Luteolin inhibits the reaction [decabromobiphenyl ether results in decreased expression of OCLN mRNA], Luteolin inhibits the reaction [decabromobiphenyl ether results in decreased expression of OCLN protein] CTD PMID:33675858 LY294002 multiple interactions EXP 6480464 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [OCLN protein results in increased phosphorylation of IL1B protein] CTD PMID:15350541 LY294002 affects localization ISO RGD:732985 6480464 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one affects the localization of OCLN protein CTD PMID:19297429 LY294002 multiple interactions ISO RGD:732985 6480464 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [lead acetate results in decreased expression of OCLN protein] CTD PMID:24200059 malaoxon multiple interactions EXP 6480464 [malaoxon co-treated with Lead] results in decreased expression of OCLN protein CTD PMID:20970449 malaoxon decreases expression EXP 6480464 malaoxon results in decreased expression of OCLN protein CTD PMID:20970449 malathion multiple interactions EXP 6480464 [Malathion co-treated with Lead] results in decreased expression of OCLN protein CTD PMID:20970449 malathion decreases expression EXP 6480464 Malathion results in decreased expression of OCLN protein CTD PMID:20970449 methamphetamine multiple interactions ISO RGD:1624078 6480464 [Neomycin co-treated with Metronidazole co-treated with Ampicillin co-treated with Vancomycin] inhibits the reaction [Methamphetamine results in decreased expression of OCLN mRNA] more ... CTD PMID:35390362 methamphetamine decreases expression ISO RGD:1624078 6480464 Methamphetamine results in decreased expression of OCLN mRNA, Methamphetamine results in decreased expression of OCLN protein CTD PMID:35390362 methotrexate affects expression ISO RGD:1624078 6480464 Methotrexate affects the expression of OCLN mRNA CTD PMID:18502557 methotrexate decreases expression ISO RGD:732985 6480464 Methotrexate results in decreased expression of OCLN mRNA CTD PMID:29027214 methotrexate decreases expression EXP 6480464 Methotrexate results in decreased expression of OCLN mRNA CTD PMID:29027214 methotrexate increases expression ISO RGD:732985 6480464 Methotrexate results in increased expression of OCLN mRNA CTD PMID:21678067 methylmercury chloride multiple interactions EXP 6480464 Bee Venoms inhibits the reaction [methylmercuric chloride results in decreased expression of OCLN mRNA] CTD PMID:34062221 methylmercury chloride decreases expression EXP 6480464 methylmercuric chloride results in decreased expression of OCLN mRNA CTD PMID:34062221 metronidazole multiple interactions ISO RGD:1624078 6480464 [Neomycin co-treated with Metronidazole co-treated with Ampicillin co-treated with Vancomycin] inhibits the reaction [Methamphetamine results in decreased expression of OCLN mRNA], [Neomycin co-treated with Metronidazole co-treated with Ampicillin co-treated with Vancomycin] inhibits the reaction [Methamphetamine results in decreased expression of OCLN protein] CTD PMID:35390362 microcystin-LR decreases expression ISO RGD:1624078 6480464 cyanoginosin LR results in decreased expression of OCLN protein CTD PMID:25986756 microcystin-LR decreases expression EXP 6480464 cyanoginosin LR results in decreased expression of OCLN protein CTD PMID:27758031 minocycline increases expression EXP 27095946 minocycline increases expression of occludin protein in left corpus callosum of rats with right carotid artery occlusion RGD mono(2-ethylhexyl) phthalate decreases expression EXP 6480464 mono-(2-ethylhexyl)phthalate results in decreased expression of OCLN protein CTD PMID:18214902 mono(2-ethylhexyl) phthalate multiple interactions EXP 6480464 [Ascorbic Acid co-treated with Vitamin E] inhibits the reaction [mono-(2-ethylhexyl)phthalate affects the localization of OCLN protein] CTD PMID:29940330 mono(2-ethylhexyl) phthalate affects localization EXP 6480464 mono-(2-ethylhexyl)phthalate affects the localization of OCLN protein CTD PMID:29940330 Monobutylphthalate decreases expression ISO RGD:732985 6480464 monobutyl phthalate results in decreased expression of OCLN protein CTD PMID:26922907 Monobutylphthalate decreases expression EXP 6480464 monobutyl phthalate results in decreased expression of OCLN protein CTD PMID:18214902 myricetin multiple interactions EXP 6480464 myricetin inhibits the reaction [Indomethacin results in decreased expression of OCLN mRNA], myricetin inhibits the reaction [Indomethacin results in decreased expression of OCLN protein] CTD PMID:33276066 N(6),N(6)-dimethyladenine multiple interactions EXP 6480464 N(6), N(6)-dimethyladenine promotes the reaction [Cadmium Chloride results in decreased expression of OCLN protein] CTD PMID:15618353 N-acetyl-L-cysteine multiple interactions ISO RGD:732985 6480464 Acetylcysteine inhibits the reaction [Arsenic Trioxide results in decreased expression of OCLN mRNA] more ... CTD PMID:29235125 more ... N-acetyl-L-cysteine multiple interactions ISO RGD:1624078 6480464 Acetylcysteine inhibits the reaction [bisphenol A results in decreased expression of OCLN mRNA] CTD PMID:33485121 neomycin multiple interactions ISO RGD:1624078 6480464 [Neomycin co-treated with Metronidazole co-treated with Ampicillin co-treated with Vancomycin] inhibits the reaction [Methamphetamine results in decreased expression of OCLN mRNA], [Neomycin co-treated with Metronidazole co-treated with Ampicillin co-treated with Vancomycin] inhibits the reaction [Methamphetamine results in decreased expression of OCLN protein] CTD PMID:35390362 nickel atom decreases expression ISO RGD:732985 6480464 Nickel results in decreased expression of OCLN mRNA CTD PMID:25583101 nitric oxide decreases expression EXP 6480464 Nitric Oxide deficiency results in decreased expression of OCLN protein CTD PMID:15763998 nitrofen increases expression EXP 6480464 nitrofen results in increased expression of OCLN mRNA CTD PMID:33484710 Nor-9-carboxy-delta9-THC multiple interactions ISO RGD:732985 6480464 [Cannabinoids results in increased abundance of 11-nor-delta(9)-tetrahydrocannabinol-9-carboxylic acid] which affects the methylation of OCLN gene CTD PMID:30521419 obeticholic acid multiple interactions ISO RGD:1624078 6480464 obeticholic acid promotes the reaction [[Dietary Fats co-treated with Dextran Sulfate] results in increased expression of OCLN protein] CTD PMID:35439472 ochratoxin A decreases expression ISO RGD:732985 6480464 ochratoxin A results in decreased expression of OCLN mRNA CTD PMID:27153755 , PMID:30763683 ochratoxin A increases acetylation ISO RGD:732985 6480464 ochratoxin A results in increased acetylation of OCLN promoter CTD PMID:29098329 ochratoxin A multiple interactions ISO RGD:732985 6480464 illite affects the reaction [ochratoxin A results in decreased expression of OCLN mRNA] CTD PMID:27153755 okadaic acid increases expression ISO RGD:732985 6480464 Okadaic Acid results in increased expression of OCLN mRNA CTD PMID:30926360 p-tert-Amylphenol decreases expression EXP 6480464 4-tert-octylphenol results in decreased expression of OCLN protein CTD PMID:15082077 papaverine decreases expression EXP 6480464 Papaverine results in decreased expression of OCLN protein CTD PMID:20728510 paracetamol decreases expression EXP 6480464 Acetaminophen results in decreased expression of OCLN mRNA CTD PMID:33387578 paraquat decreases expression ISO RGD:732985 6480464 Paraquat results in decreased expression of OCLN protein CTD PMID:30698896 patulin increases degradation ISO RGD:732985 6480464 Patulin results in increased degradation of OCLN protein CTD PMID:19013514 patulin multiple interactions ISO RGD:732985 6480464 1 more ... CTD PMID:19013514 perfluorooctane-1-sulfonic acid multiple interactions ISO RGD:1624078 6480464 Matrix Metalloproteinase Inhibitors inhibits the reaction [perfluorooctane sulfonic acid results in decreased expression of OCLN protein], SB 203580 inhibits the reaction [perfluorooctane sulfonic acid results in decreased expression of OCLN protein] CTD PMID:23761298 , PMID:27818224 perfluorooctane-1-sulfonic acid multiple interactions ISO RGD:732985 6480464 CID755673 inhibits the reaction [perfluorooctane sulfonic acid results in decreased expression of OCLN protein] CTD PMID:36106993 perfluorooctane-1-sulfonic acid decreases expression ISO RGD:732985 6480464 perfluorooctane sulfonic acid results in decreased expression of OCLN protein CTD PMID:32700164 , PMID:36106993 perfluorooctane-1-sulfonic acid decreases expression ISO RGD:1624078 6480464 perfluorooctane sulfonic acid results in decreased expression of OCLN protein CTD PMID:23761298 , PMID:27818224 perfluorooctanoic acid increases expression ISO RGD:732985 6480464 perfluorooctanoic acid results in increased expression of OCLN protein CTD PMID:26879310 perfluorooctanoic acid decreases expression ISO RGD:1624078 6480464 perfluorooctanoic acid results in decreased expression of OCLN protein CTD PMID:25743374 , PMID:35066053 permethrin multiple interactions ISO RGD:1624078 6480464 [Permethrin co-treated with Pyridostigmine Bromide co-treated with Corticosterone] results in decreased expression of OCLN protein, Butyric Acid inhibits the reaction [[Permethrin co-treated with Pyridostigmine Bromide co-treated with Corticosterone] results in decreased expression of OCLN protein] CTD PMID:29751049 phenobarbital increases expression ISO RGD:1624078 6480464 Phenobarbital results in increased expression of OCLN mRNA CTD PMID:19270015 phenobarbital affects expression ISO RGD:1624078 6480464 Phenobarbital affects the expression of OCLN mRNA CTD PMID:23091169 phenobarbital affects expression ISO RGD:732985 6480464 Phenobarbital affects the expression of OCLN mRNA CTD PMID:19159669 phoxim multiple interactions EXP 6480464 Vitamin E inhibits the reaction [phoxim results in decreased expression of OCLN mRNA] CTD PMID:30003487 phoxim decreases expression EXP 6480464 phoxim results in decreased expression of OCLN mRNA CTD PMID:30003487 pirinixic acid decreases expression ISO RGD:1624078 6480464 pirinixic acid results in decreased expression of OCLN mRNA CTD PMID:18445702 poly(vinylpyrrolidone) affects expression ISO RGD:732985 6480464 Povidone affects the expression of OCLN mRNA CTD PMID:19729060 potassium dichromate increases expression EXP 6480464 Potassium Dichromate results in increased expression of OCLN protein CTD PMID:19766176 potassium dichromate decreases expression EXP 6480464 Potassium Dichromate results in decreased expression of OCLN mRNA, Potassium Dichromate results in decreased expression of OCLN protein CTD PMID:28192182 potassium iodide decreases expression EXP 6480464 Potassium Iodide results in decreased expression of OCLN mRNA CTD PMID:32593569 pregnenolone 16alpha-carbonitrile decreases expression EXP 6480464 Pregnenolone Carbonitrile results in decreased expression of OCLN mRNA CTD PMID:19162173 probenecid multiple interactions ISO RGD:1624078 6480464 [Probenecid co-treated with 1-Methyl-4-phenyl-1 more ... CTD PMID:25064079 progesterone decreases expression ISO RGD:1624078 6480464 Progesterone results in decreased expression of OCLN mRNA CTD PMID:22238285 propiconazole decreases expression ISO RGD:1624078 6480464 propiconazole results in decreased expression of OCLN mRNA CTD PMID:21278054 Pyridostigmine bromide multiple interactions ISO RGD:1624078 6480464 [Permethrin co-treated with Pyridostigmine Bromide co-treated with Corticosterone] results in decreased expression of OCLN protein, Butyric Acid inhibits the reaction [[Permethrin co-treated with Pyridostigmine Bromide co-treated with Corticosterone] results in decreased expression of OCLN protein] CTD PMID:29751049 quercetin affects localization ISO RGD:732985 6480464 Quercetin affects the localization of OCLN protein modified form CTD PMID:19297429 quercetin multiple interactions EXP 6480464 Quercetin inhibits the reaction [Indomethacin results in decreased expression of OCLN mRNA], Quercetin inhibits the reaction [Indomethacin results in decreased expression of OCLN protein] CTD PMID:33276066 quercetin decreases expression EXP 6480464 Quercetin results in decreased expression of OCLN mRNA, Quercetin results in decreased expression of OCLN protein CTD PMID:28431985 quercetin multiple interactions ISO RGD:732985 6480464 Quercetin inhibits the reaction [Hydrogen Peroxide results in decreased expression of OCLN protein], Quercetin inhibits the reaction [Indomethacin results in decreased expression of OCLN mRNA] CTD PMID:20445016 , PMID:23668856 quercitrin affects expression ISO RGD:732985 6480464 quercitrin affects the expression of OCLN mRNA CTD PMID:25193878 raloxifene multiple interactions ISO RGD:732985 6480464 [Raloxifene Hydrochloride co-treated with ESR2 protein] results in increased expression of OCLN mRNA CTD PMID:19059307 resveratrol decreases expression ISO RGD:732985 6480464 resveratrol results in decreased expression of OCLN mRNA CTD PMID:20816778 resveratrol multiple interactions ISO RGD:1624078 6480464 Resveratrol inhibits the reaction [Aluminum Chloride results in decreased expression of OCLN mRNA], Resveratrol inhibits the reaction [Aluminum Chloride results in decreased expression of OCLN protein] CTD PMID:34614429 , PMID:35156769 resveratrol multiple interactions ISO RGD:732985 6480464 Resveratrol inhibits the reaction [Arsenic Trioxide results in decreased expression of OCLN protein] CTD PMID:32683294 rifampicin affects localization ISO RGD:1624078 6480464 Rifampin affects the localization of OCLN protein CTD PMID:19577586 rotenone multiple interactions ISO RGD:732985 6480464 Rotenone inhibits the reaction [Particulate Matter results in decreased expression of OCLN protein] CTD PMID:28724416 rottlerin affects localization ISO RGD:732985 6480464 rottlerin affects the localization of OCLN protein modified form CTD PMID:19297429 Salidroside multiple interactions ISO RGD:1624078 6480464 rhodioloside affects the reaction [furan results in decreased expression of OCLN protein], rhodioloside inhibits the reaction [Streptozocin results in decreased expression of OCLN protein] CTD PMID:31682803 , PMID:32251705 SB 203580 multiple interactions ISO RGD:732985 6480464 SB 203580 inhibits the reaction [Arsenic Trioxide results in decreased expression of OCLN protein], SB 203580 inhibits the reaction [Clopidogrel results in decreased expression of OCLN protein] CTD PMID:23220562 , PMID:32683294 SB 203580 multiple interactions ISO RGD:1624078 6480464 SB 203580 inhibits the reaction [perfluorooctane sulfonic acid results in decreased expression of OCLN protein] CTD PMID:23761298 , PMID:27818224 SB 431542 multiple interactions ISO RGD:732985 6480464 [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of OCLN mRNA CTD PMID:27188386 selenium atom multiple interactions ISO RGD:732985 6480464 [gamma-Linolenic Acid co-treated with Iodine co-treated with Selenium] results in increased expression of and results in increased localization of OCLN protein more ... CTD PMID:16514648 serpentine asbestos decreases expression ISO RGD:732985 6480464 Asbestos, Serpentine results in decreased expression of OCLN protein CTD PMID:30609805 simvastatin increases expression EXP 6480464 Simvastatin results in increased expression of OCLN CTD PMID:18544044 sodium arsenite multiple interactions ISO RGD:732985 6480464 sodium arsenite affects the phosphorylation of and results in increased expression of OCLN protein CTD PMID:24349408 sodium arsenite affects expression ISO RGD:732985 6480464 sodium arsenite affects the expression of OCLN mRNA CTD PMID:34032870 sodium arsenite decreases expression ISO RGD:732985 6480464 sodium arsenite results in decreased expression of OCLN mRNA CTD PMID:28595984 sodium arsenite affects localization ISO RGD:1624078 6480464 sodium arsenite affects the localization of OCLN protein CTD PMID:24349408 sodium arsenite increases expression ISO RGD:732985 6480464 sodium arsenite results in increased expression of OCLN protein CTD PMID:24349408 sodium fluoride decreases expression ISO RGD:1624078 6480464 Sodium Fluoride results in decreased expression of OCLN mRNA CTD PMID:27237588 sodium sulfide (anhydrous) multiple interactions ISO RGD:1624078 6480464 [Hydrogen Sulfide results in increased abundance of sodium sulfide] which results in decreased expression of OCLN protein more ... CTD PMID:33068716 Soman decreases expression EXP 6480464 Soman results in decreased expression of OCLN mRNA CTD PMID:19281266 streptozocin multiple interactions ISO RGD:1624078 6480464 rhodioloside inhibits the reaction [Streptozocin results in decreased expression of OCLN protein] CTD PMID:31682803 streptozocin decreases expression ISO RGD:1624078 6480464 Streptozocin results in decreased expression of OCLN protein CTD PMID:31682803 sulfasalazine multiple interactions EXP 6480464 Sulfasalazine inhibits the reaction [Trinitrobenzenesulfonic Acid results in decreased expression of OCLN mRNA], Sulfasalazine inhibits the reaction [Trinitrobenzenesulfonic Acid results in decreased expression of OCLN protein] CTD PMID:35290143 sunitinib decreases expression ISO RGD:732985 6480464 Sunitinib results in decreased expression of OCLN mRNA CTD PMID:31533062 T-2 toxin multiple interactions ISO RGD:732985 6480464 illite inhibits the reaction [T-2 Toxin results in decreased expression of OCLN mRNA] CTD PMID:27153755 T-2 toxin decreases expression ISO RGD:732985 6480464 T-2 Toxin results in decreased expression of OCLN mRNA, T-2 Toxin results in decreased expression of OCLN protein CTD PMID:27153755 , PMID:31170431 tamibarotene increases expression ISO RGD:732985 6480464 tamibarotene results in increased expression of OCLN mRNA CTD PMID:16982755 tamoxifen multiple interactions ISO RGD:732985 6480464 [Tamoxifen co-treated with ESR2 protein] results in increased expression of OCLN mRNA CTD PMID:19059307 tectorigenin multiple interactions ISO RGD:1624078 6480464 tectorigenin inhibits the reaction [Dietary Fats results in decreased expression of OCLN mRNA], tectorigenin inhibits the reaction [Dietary Fats results in decreased expression of OCLN protein] CTD PMID:35390440 telmisartan multiple interactions ISO RGD:1624078 6480464 Telmisartan affects the reaction [LEPR protein affects the expression of OCLN mRNA] CTD PMID:34464088 telmisartan multiple interactions ISO RGD:732985 6480464 MYLK protein inhibits the reaction [Telmisartan inhibits the reaction [Glucose results in decreased expression of OCLN mRNA]] more ... CTD PMID:34464088 tert-butyl hydroperoxide decreases expression EXP 6480464 tert-Butylhydroperoxide results in decreased expression of OCLN protein CTD PMID:34303734 testosterone decreases expression ISO RGD:732985 6480464 Testosterone results in decreased expression of OCLN mRNA CTD PMID:33359661 tetrachloroethene increases expression ISO RGD:1624078 6480464 Tetrachloroethylene results in increased expression of OCLN mRNA CTD PMID:28973375 tetrachloromethane multiple interactions ISO RGD:1624078 6480464 ginkgolide A inhibits the reaction [Carbon Tetrachloride results in decreased expression of OCLN protein] CTD PMID:31697926 tetrachloromethane decreases expression ISO RGD:1624078 6480464 Carbon Tetrachloride results in decreased expression of OCLN protein CTD PMID:31697926 thalidomide multiple interactions ISO RGD:1624078 6480464 Thalidomide inhibits the reaction [dinitrobenzenesulfonic acid results in decreased expression of OCLN protein] CTD PMID:16680017 thioacetamide increases expression EXP 6480464 Thioacetamide results in increased expression of OCLN mRNA, Thioacetamide results in increased expression of OCLN protein CTD PMID:15350541 , PMID:23411599 tioguanine decreases activity ISO RGD:732985 6480464 Thioguanine results in decreased activity of OCLN protein CTD PMID:17015055 titanium dioxide increases expression ISO RGD:1624078 6480464 titanium dioxide results in increased expression of OCLN mRNA CTD PMID:23557971 , PMID:32333507 toluene increases expression EXP 6480464 Toluene results in increased expression of OCLN mRNA CTD PMID:22967744 trichloroethene decreases expression EXP 6480464 Trichloroethylene results in decreased expression of OCLN mRNA CTD PMID:33387578 trichostatin A increases expression ISO RGD:732985 6480464 trichostatin A results in increased expression of OCLN mRNA CTD PMID:18661270 trichostatin A decreases expression ISO RGD:732985 6480464 trichostatin A results in decreased expression of OCLN mRNA CTD PMID:24935251 triclosan decreases expression ISO RGD:732985 6480464 Triclosan results in decreased expression of OCLN mRNA CTD PMID:30510588 triphenyl phosphate decreases expression ISO RGD:1624078 6480464 triphenyl phosphate results in decreased expression of OCLN mRNA CTD PMID:35752650 Triptolide decreases expression ISO RGD:1624078 6480464 triptolide results in decreased expression of OCLN mRNA, triptolide results in decreased expression of OCLN protein CTD PMID:30836114 Triptolide multiple interactions ISO RGD:1624078 6480464 mitoquinone inhibits the reaction [triptolide results in decreased expression of OCLN mRNA], mitoquinone inhibits the reaction [triptolide results in decreased expression of OCLN protein] CTD PMID:30836114 troglitazone decreases expression ISO RGD:1624078 6480464 troglitazone results in decreased expression of OCLN mRNA CTD PMID:28973697 uranium atom increases expression EXP 6480464 Uranium analog results in increased expression of OCLN mRNA CTD PMID:27544493 valproic acid increases expression ISO RGD:732985 6480464 Valproic Acid results in increased expression of OCLN mRNA CTD PMID:19101580 valproic acid multiple interactions ISO RGD:732985 6480464 [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of OCLN mRNA CTD PMID:27188386 valproic acid decreases expression ISO RGD:732985 6480464 Valproic Acid results in decreased expression of OCLN mRNA CTD PMID:23179753 , PMID:26272509 vancomycin multiple interactions ISO RGD:1624078 6480464 [Neomycin co-treated with Metronidazole co-treated with Ampicillin co-treated with Vancomycin] inhibits the reaction [Methamphetamine results in decreased expression of OCLN mRNA], [Neomycin co-treated with Metronidazole co-treated with Ampicillin co-treated with Vancomycin] inhibits the reaction [Methamphetamine results in decreased expression of OCLN protein] CTD PMID:35390362 vinclozolin increases methylation EXP 6480464 vinclozolin results in increased methylation of OCLN gene CTD PMID:31682807 vitamin E multiple interactions EXP 6480464 [Ascorbic Acid co-treated with Vitamin E] inhibits the reaction [mono-(2-ethylhexyl)phthalate affects the localization of OCLN protein], Vitamin E inhibits the reaction [phoxim results in decreased expression of OCLN mRNA] CTD PMID:29940330 , PMID:30003487 zafirlukast multiple interactions ISO RGD:732985 6480464 zafirlukast inhibits the reaction [[Oxygen deficiency co-treated with Blood Glucose deficiency] results in decreased expression of OCLN mRNA], zafirlukast inhibits the reaction [[Oxygen deficiency co-treated with Blood Glucose deficiency] results in decreased expression of OCLN protein] CTD PMID:31816286 zafirlukast multiple interactions ISO RGD:1624078 6480464 zafirlukast inhibits the reaction [[Oxygen deficiency co-treated with Blood Glucose deficiency] results in decreased expression of OCLN mRNA], zafirlukast inhibits the reaction [[Oxygen deficiency co-treated with Blood Glucose deficiency] results in decreased expression of OCLN protein] CTD PMID:31816286 zileuton multiple interactions ISO RGD:1624078 6480464 zileuton inhibits the reaction [dinitrobenzenesulfonic acid affects the localization of OCLN protein] CTD PMID:16670640 zinc sulfate multiple interactions ISO RGD:732985 6480464 Zinc Sulfate inhibits the reaction [Patulin results in increased degradation of OCLN protein] CTD PMID:19013514
